Horse Gastric Ulcer Advanced Treatment: When Omeprazole Alone Is Insufficient

Some cases of equine gastric ulcer syndrome require combination therapy and management changes beyond standard omeprazole treatment for adequate welfare outcomes.

Key Facts

Equine glandular gastric disease responds less predictably to omeprazole than squamous disease
Sucralfate and misoprostol are used as adjunct treatments for glandular EGUS with some evidence of benefit
Stress reduction through management change is essential alongside pharmacological treatment
Horses on omeprazole that worsen or fail to improve may have glandular disease requiring different treatment
Repeated gastroscopy is the only reliable way to assess treatment response and guide dose adjustment

Welfare Considerations

Treating equine gastric ulcers as a single condition requiring standard omeprazole therapy is now recognized as an oversimplification with welfare consequences. Glandular disease, which occurs in the lower, acid-resistant stomach region, involves a different pathological mechanism and responds poorly to acid suppression alone. Horses with glandular EGUS that receive only omeprazole experience continued pain despite treatment. Welfare-positive treatment requires distinguishing squamous from glandular disease through gastroscopy, applying appropriate therapy for each type, and making the management and stress reduction changes that address underlying predisposing factors.

What You Can Do

Ensure gastroscopy includes assessment of both squamous and glandular regions before starting treatment
If your horse does not respond to standard omeprazole within 4-6 weeks, request repeat gastroscopy to reassess
Discuss glandular-specific treatment options including sucralfate with your equine vet
Address management stressors alongside pharmacological treatment — neither alone is sufficient
Support research into glandular EGUS pathogenesis and optimal treatment protocols